134 related articles for article (PubMed ID: 15030994)
1. Atorvastatin as a trigger of autoimmune hepatitis.
Pelli N; Setti M
J Hepatol; 2004 Apr; 40(4):716. PubMed ID: 15030994
[No Abstract] [Full Text] [Related]
2. Drug-induced acute autoimmune hepatitis during combination therapy with atorvastatin and ezetimibe.
van Heyningen C
Ann Clin Biochem; 2005 Sep; 42(Pt 5):402-4. PubMed ID: 16168199
[TBL] [Abstract][Full Text] [Related]
3. Fatal liver failure with atorvastatin.
Perger L; Kohler M; Fattinger K; Flury R; Meier PJ; Pauli-Magnus C
J Hepatol; 2003 Dec; 39(6):1095-7. PubMed ID: 14642636
[No Abstract] [Full Text] [Related]
4. Drug-induced lupus-like syndrome associated with severe autoimmune hepatitis.
Graziadei IW; Obermoser GE; Sepp NT; Erhart KH; Vogel W
Lupus; 2003; 12(5):409-12. PubMed ID: 12765306
[TBL] [Abstract][Full Text] [Related]
5. Atorvastatin-induced acute hepatitis with absence of cross-toxicity with simvastatin.
Nakad A; Bataille L; Hamoir V; Sempoux C; Horsmans Y
Lancet; 1999 May; 353(9166):1763-4. PubMed ID: 10347994
[No Abstract] [Full Text] [Related]
6. Rosuvastatin-associated hepatitis with autoimmune features.
Wolters LM; Van Buuren HR
Eur J Gastroenterol Hepatol; 2005 May; 17(5):589-90. PubMed ID: 15827453
[No Abstract] [Full Text] [Related]
7. Dermographism: an adverse effect of atorvastatin.
Adcock BB; Hornsby LB; Jenkins K
J Am Board Fam Pract; 2001; 14(2):148-51. PubMed ID: 11314923
[No Abstract] [Full Text] [Related]
8. Statins, fibrates, and ocular myasthenia.
Parmar B; Francis PJ; Ragge NK
Lancet; 2002 Aug; 360(9334):717. PubMed ID: 12241896
[No Abstract] [Full Text] [Related]
9. Cholestatic liver dysfunction.
Wierzbicki AS; Crook MA
Lancet; 1999 Sep; 354(9182):954. PubMed ID: 10489985
[No Abstract] [Full Text] [Related]
10. [Side effects of the HMG-CoA reductase inhibitors (statins). Lupus erythematosus induced by Atorvastatin therapy].
Hydzik P; Szpak D
Przegl Lek; 2011; 68(8):495-8. PubMed ID: 22010448
[TBL] [Abstract][Full Text] [Related]
11. Binder wars.
Martinez DG
Am J Kidney Dis; 2008 Nov; 52(5):1024; author reply 1025. PubMed ID: 18971020
[No Abstract] [Full Text] [Related]
12. Autoimmune hepatitis triggered by statins.
Alla V; Abraham J; Siddiqui J; Raina D; Wu GY; Chalasani NP; Bonkovsky HL
J Clin Gastroenterol; 2006 Sep; 40(8):757-61. PubMed ID: 16940892
[TBL] [Abstract][Full Text] [Related]
13. Atorvastatin-induced polyneuropathy.
Jacobs MB
Ann Intern Med; 2004 Jul; 141(1):77. PubMed ID: 15238379
[No Abstract] [Full Text] [Related]
14. Atorvastatin-induced polyneuropathy.
Silverberg C
Ann Intern Med; 2003 Nov; 139(9):792-3. PubMed ID: 14597471
[No Abstract] [Full Text] [Related]
15. [The last round about statins: there is the fact that 80 mg simvastatin daily results in high risk of myopathy].
Olsson AG
Lakartidningen; 2009 Oct 21-27; 106(43):2783-4; author reply 2784. PubMed ID: 19960911
[No Abstract] [Full Text] [Related]
16. Atorvastatin-induced reversible positive antinuclear antibodies.
Jiménez-Alonso J; Jaimez L; Sabio JM; Hidalgo C; Leon L
Am J Med; 2002 Mar; 112(4):329-30. PubMed ID: 11893380
[No Abstract] [Full Text] [Related]
17. [Pubalgia in athlete treated by atorvastatin].
Andrès E; Alt M
Presse Med; 2009 Apr; 38(4):667. PubMed ID: 19135332
[No Abstract] [Full Text] [Related]
18. A piece of my mind: A pain in the tuches.
Gropp C
JAMA; 2012 Dec; 308(23):2467-8. PubMed ID: 23287848
[No Abstract] [Full Text] [Related]
19. Rhabdomyolysis developing secondary to atorvastatin therapy in a patient with liver cirrhosis.
Eshraghian A; Kamyab AA
Intern Med; 2013; 52(7):823-5. PubMed ID: 23545684
[TBL] [Abstract][Full Text] [Related]
20. [Detection of auto-antibodies for diagnosing auto-immunous hepatitis].
Tan LM; Dong Y; Li H; Liu N; Cai LL; Wang YY; Ao JY
Zhonghua Gan Zang Bing Za Zhi; 2006 Jun; 14(6):463-4. PubMed ID: 16792876
[No Abstract] [Full Text] [Related]
[Next] [New Search]
